Downregulation of YBX1 observed in the current study in LEAD vs. AAA subjects (Table 2) may indicate enhanced oxidized LDL-mediated inflammatory response and lipid deposition in macrophages [73], what is characteristic for pathogenesis of atherosclerosis, and hence LEAD. The gene discussed is YBX1; the disease is triple-A syndrome.